Skip to content
Screener

Haemonetics HAE Shares (Diluted)

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B-0.4%
TFX
TeleflexTFX
43.7M-1.5%
Boston Scientific logo
Boston ScientificBSX
1.5B-1.3%
Medtronic logo
MedtronicMDT
1.3B-0.1%
LivaNova logo
LivaNovaLIVN
56.3M+2.9%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
20.9M-1.1%

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.87B+6.3%
Enterprise value$4.82B+5.4%
P/E25.7×-10.5×
P/S2.9×+0.2×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025
Provision for income taxes14,56411,138
Net income$33,010$34,031
Net income per common share:
Basic$0.73$0.71
Diluted$0.72$0.70
Weighted average shares outstanding
Basic45,36148,111
Diluted45,70448,353

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's shares (diluted)?
Haemonetics (HAE) reported shares (diluted) of 45.7M in Q2 2026.
How has Haemonetics's shares (diluted) changed year-over-year?
Haemonetics's shares (diluted) decreased by 5.5% year-over-year, from 48.4M to 45.7M.
What is the long-term trend for Haemonetics's shares (diluted)?
Over 4 years (2022 to 2026), Haemonetics's shares (diluted) has grown at a -1.8% compound annual growth rate (CAGR), from 205.1M to 190.4M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Haemonetics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude